Your account is not claimed yet. You can sign up with ORCID to claim your account.

Adrian F Ochsenbein (A F Ochsenbein)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 8

Top Venues

Nature communications

Science signaling

Nature medicine

The Journal of experimental medicine

Insel Gruppe AG

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Insel Gruppe AG

Switzerland

Chairman :: Medical Oncology

Publications

Roberta Esposito, Andrés Lanzós, Tina Uroda, Sunandini Ramnarayanan, Isabel Büchi, Taisia Polidori, Hugo Guillen-Ramirez, Ante Mihaljevic, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Lusine Hovhannisyan, Finn McCluggage, Matúš Medo, Giulia Basile, Dominik F Meise, Sandra Zwyssig, Corina Wenger, Kyriakos Schwarz, Adrienne Vancura, Núria Bosch-Guiteras, Alvaro Andrades, Ai Ming Tham, Michaela Roemmele, Pedro P Medina, Adrian F Ochsenbein, Carsten Riether, Marianna Kruithof de Julio, Yitzhak Zimmer, Michaela Medová, Deborah M Stroka, Archa Fox, Rory Johnson
Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness. Nature communications 14 (1) (2023)
Pascal Naef, Ramin Radpour, Carla A Jaeger, Nils Bodmer, Gabriela M Baerlocher, Hartmut Döhner, Konstanze Doehner, Carsten Riether, Adrian F Ochsenbein
IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Science signaling 16 (800) (2023)
Roberta Esposito, Andrés Lanzós, Tina Uroda, Sunandini Ramnarayanan, Isabel Büchi, Taisia Polidori, Hugo Guillen-Ramirez, Ante Mihaljevic, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Lusine Hovhannisyan, Finn McCluggage, Matúš Medo, Giulia Basile, Dominik F Meise, Sandra Zwyssig, Corina Wenger, Kyriakos Schwarz, Adrienne Vancura, Núria Bosch-Guiteras, Alvaro Andrades, Ai Ming Tham, Michaela Roemmele, Adrian F Ochsenbein, Carsten Riether, Marianna Kruithof de Julio, Yitzhak Zimmer, Michaela Medová, Deborah M Stroka, Archa Fox, Rory Johnson
Tumour mutations in long noncoding RNAs enhance cell fitness. Nature communications 14 (1) (2023)
Elias D Bührer, Michael A Amrein, Stefan Forster, Stephan Isringhausen, Christian M Schürch, Salil S Bhate, Tess Brodie, Joel Zindel, Deborah Stroka, Mohamad Al Sayed, Cesar Nombela-Arrieta, Ramin Radpour, Carsten Riether, Adrian F Ochsenbein
Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance. Leukemia 36 (11) (2022)
S S Höpner, Ana Raykova, Ramin Radpour, Michael A Amrein, D Koller, G M Baerlocher, Carsten Riether, Adrian F Ochsenbein
LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells. Nature communications 12 (1) (2021)
Carsten Riether, Thomas Pabst, Sabine Höpner, Ulrike Bacher, Magdalena Hinterbrandner, Yara Banz, Rouven Müller, Markus Gabriel Manz, Walid H Gharib, David Francisco, Remy Bruggmann, Luc van Rompaey, Mahan Moshir, Tim Delahaye, Domenica Gandini, Ellen Erzeel, Anna Hultberg, Samson Fung, Hans de Haard, Nicolas Leupin, Adrian F Ochsenbein
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nature medicine 26 (9) (2020)
Mohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, Christina Claus, Jean-Pierre Bourquin, Beat C Bornhauser, Ramin Radpour, Carsten Riether, Adrian F Ochsenbein
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood 130 (3) (2017)
Carsten Riether, Christian M Schürch, Elias D Bührer, Magdalena Hinterbrandner, Anne-Laure Huguenin, Sabine Hoepner, Inti Zlobec, Thomas Pabst, Ramin Radpour, Adrian F Ochsenbein
CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. The Journal of experimental medicine 214 (2) (2016)

Adrian F Ochsenbein.css-eqlu8i{font-size:small;padding-left:4px;} (A F Ochsenbein)

Publication Activity (10 Years)

Top Topics

Top Venues

Adrian F Ochsenbein (A F Ochsenbein)